2009-10-28 16:16:12 -

Novartis announced today the completion of the new 1 megawatt (MW) solar array near its Vacaville biopharmaceutical site. The announcement was made at a ceremony which celebrated the collective effort of state and local officials, employees and business partners in championing the approval, construction and completion of the $7 million dollar power plant. The five acre array will supply 20% of the manufacturing facility’s electrical needs.

As the Group’s single largest solar energy investment, the Vacaville array more than triples the total solar power generation by Novartis facilities worldwide. In recognizing this, Robert Pelzer, CEO of Novartis Corporation, said, “Today’s dedication signals our continued commitment to the environment and to initiatives like the Kyoto Protocol, the US EPA Climate Leaders Program

and our own US Energy program.”


“Novartis has demonstrated outstanding leadership and teamwork as an active and enthusiastic community partner,” shared City of Vacaville, Mayor Len Augustine, “and together we are once again demonstrating that industry and government working together on common goals can be an effective force in promoting renewable energy and environmental responsibility.”


Made up of over 4,100 photovoltaic panels, the Novartis system eliminates the production of over 1,400 metric tons of greenhouse gases annually. This is the equivalent of removing 257 passenger vehicles from the road or planting 319 acres of new forest per year. The Vacaville power plant joins five other Novartis solar sites, and numerous other renewal energy operations, around the world in supporting the Group’s goal of reducing, by 2012, its greenhouse gas emissions to 5% below its 1990 level.

Initiated in 2006 by employees at the Vacaville site, and introduced as part of a corporate Energy Excellence Award program, the project benefits from Vacaville’s ideal location for solar power generation, having 25% more sunny days than the average American city. A first phase of the project, a 30 kW parking canopy, was completed in December 2008, with the larger 970 kW array becoming operational in mid-September of this year, a full month ahead of schedule.

Joining Robert Pelzer, Mayor Augustine, and Rob Carter, Vacaville Site Head, in the ribbon cutting ceremony were Novartis employees and 4th grade students from Browns Valley Elementary School in Vacaville, who participated in educational activities. As “Solar Champions” for the day, the students were the first to take part in a planned local program by Novartis to educate local youth on the benefits of renewable energy.



Disclaimer

Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.


About Novartis

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2008, the Group’s continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 99,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit www.novartis.com : .



Novartis Media Relations:Novartis CorporationPamela

McKinlay, 212-830-2465 (office) or 862-221-0151 (mobile) pamela.mckinlay@novartis.com : mailto:pamela.mckinlay@novartis.com Novartis
BPO VacavilleJoe Culley, 707-452-2430 (office) or
707-365-8174 (mobile) joe.culley@novartis.com : mailto:joe.culley@novartis.com media.relations@novartis.com : mailto:media.relations@novartis.com orNovartis
Investor Relations:Central phone: +41 61 324 7944Ruth

Metzler-Arnold, +41 61 324 9980Pierre-Michel Bringer, +41 61 324
1065John Gilardi, +41 61 324 3018Thomas Hungerbuehler, +41

61 324 8425Isabella Zinck, +41 61 324 7188 investor.relations@novartis.com : mailto:investor.relations@novartis.com North

America:Richard Jarvis, +1 212-830-2433Jill Pozarek, +1
212-830-2445Edwin Valeriano, +1 212-830-2456 investor.relations@novartis.com : mailto:investor.relations@novartis.com